APA (7th ed.) Citation

Tang, S., Zhang, Y., Luo, S., Wang, W., Wu, X., Zhao, X., & Leng, Y. (2025). METTL9 as a protein biomarker predicts the prognosis and immunotherapy response of skin-cutaneous melanoma. Annals of medicine and surgery, 87(8), 4918-4925. https://doi.org/10.1097/MS9.0000000000003480

Chicago Style (17th ed.) Citation

Tang, Song, Yiran Zhang, Simin Luo, Wendan Wang, Xunxin Wu, Xiaoxu Zhao, and Yin Leng. "METTL9 as a Protein Biomarker Predicts the Prognosis and Immunotherapy Response of Skin-cutaneous Melanoma." Annals of Medicine and Surgery 87, no. 8 (2025): 4918-4925. https://doi.org/10.1097/MS9.0000000000003480.

MLA (9th ed.) Citation

Tang, Song, et al. "METTL9 as a Protein Biomarker Predicts the Prognosis and Immunotherapy Response of Skin-cutaneous Melanoma." Annals of Medicine and Surgery, vol. 87, no. 8, 2025, pp. 4918-4925, https://doi.org/10.1097/MS9.0000000000003480.